TUDCA has been given to human patients in registered amyloidosis trials, paired with prescription doxycycline. This is the clearest case of TUDCA’s chaperone activity being tested in people, and also the clearest case of why it is not a supplement protocol.
A bile acid cut infarct size roughly in half in a rat stroke model. That was 2002. Two decades later there is still no human stroke trial. Here is what the research showed and why the gap matters.
PBC is the one condition where TUDCA has been tested head-to-head against standard-of-care UDCA in a randomized trial. Here is what those human studies found, and why that does not make TUDCA a substitute for prescription treatment.
TUDCA and alcohol: what cell studies, bile acid research in alcoholic hepatitis, and TUDCA’s liver trial data actually show — and don’t show.
TUDCA is a naturally occurring bile acid studied for liver protection, neurological health, and metabolic support. Learn what it is, how it works, and what the
TUDCA and phosphatidylcholine protect the liver through distinct mechanisms. Compare their proposed actions, evidence base, and practical differences here.
A review of preclinical evidence on TUDCA and photoreceptor protection in retinal degeneration, including proposed mechanisms and animal model findings.
A structured TUDCA protocol for oral steroid cycles — pre-load, on-cycle, and post-cycle dosing with honest evidence review and safety caveats.
TUDCA blocks Bax-driven cytochrome c release and Bad activation to inhibit mitochondrial apoptosis. Here is what the research shows.
What do animal studies show about TUDCA’s neuroprotective potential in Huntington’s disease? An honest summary of the preclinical evidence and its limits.
TUDCA may interact with cyclosporine, bile acid sequestrants, thyroid drugs, and antacids. Learn the mechanisms and what to discuss with your doctor.
In the evolving landscape of health optimization, individuals are increasingly seeking evidence-based solutions to support organ function, cognitive health, and